Systematic Reviews
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jan 28, 2016; 22(4): 1721-1726
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1721
Table 1 The prevalence of vascular invasion in rectal cancer
AuthorYearNo. patientsStudy designNo. of pathologists, blindingStainTumoursiteElastin stainNo. EMVI +ve ptsPrev VI +veEMVI +ve 5 yr survivalIndependent prognosticator
Brown et al[29]1938170RetrospectiveUnspecifiedH + ERectumYes10461%No 5 yr dataNo comment
Dukes et al[30]1941689ProspectiveUnspecifiedNo stainRectumNo10717%No 5 yr dataNo comment
Seefeld et al[13]1943100Prospective1, blindedH + E, Gieson’sRectumYes2020%5%No comment
Madison et al[31]195442ProspectiveUnspecifiedBrominol, H + E, Gieson’sRectumYes1943%No 5 yr dataNo comment
Carroll[17]19631996RetrospectiveUnspecifiedH + ERectumNo24011.8%36%No comment
Khankhanian et al[32]1977143RetrospectiveUnspecifiedNot statedRectumNo7019% (BVI + LVI)Data not usableEMVI is +ve IPS
Talbot et al[6]1980706Prospective2, blindedH + E, elastinRectumYes36652%33% EMVI+veNo comment
Rich et al[15]1983142Prospective1, blindedH + ERS/RectumNo2317%No 5 yr dataNo comment
Freedman et al[4]1984494RetrospectiveUnspecifiedNo commentRectumYes8936%31% EMVI+veNo comment
Jass et al[16]1986447Prospective1, blindedH + ERectumNo11626% (extramural only)41% EMVI+veEMVI - No IPS
Sasaki et al[33]1987774RetrospectiveUnspecifiedH + ERectumNo16321% (extramural only)No 5 yr dataNo comment
Minsky et al[14]1988168Retrospective1, blindedH + E, elastinRS/RectumYes8148%33% EMVI+veEMVI - No IPS
Harrison et al[2]1994348Retrospective2, blindedH + E, elastinRectumYes7421.2%21% EMVI+veEMVI has IPS
Ptok et al[18]20061043RetrospectiveUnspecifiedNot stateRectumNo759%80.7% LVI +veEMVI - No IPS